The effects of novel medicinal cannabis formulation IHL-42X on apnoea hypopnea index in adults with suspected or diagnosed mild to moderate obstructive sleep apnoea.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2019
This article has no abstract
Epistemonikos ID: 8f7a32354af1493246b9e1f99befb21433d03602
First added on: Mar 17, 2025